Jun 2026 (Q2 FY26) — Aug 12, 2026
STAAR Surgical Q2 FY26 — Record First Half Revenue, Strong Profitability, and EVO Plus Momentum
Read the full callSTAAR Surgical (STAA) earnings
- Jul 2026
- Jun 2026 (Q2 FY26)
- Jan 2026
STAAR Surgical earnings: last reported Wed, 12 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 93.5 | +111.0% YoY | Quarterly, as filed | Quarter to Jul 2026 | Revenue from operations as filed. |
| Operating margin | 10.8 | +78.4 pts YoY | Operating profit / revenue | Quarter to Jul 2026 | For the quarter; a change is in percentage points. |
| Net profit | 8.1 | Quarterly, as filed | Quarter to Jul 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$21.88 +2.87% · +$0.61
Performance −12.6% 1Y
1Y: $25.03 on 17 Oct 2025 → $21.88. High $33.34 (26 May 2026), low $16.1 (13 Feb 2026).
- Previous close
- $21.27
- 52-week range
- $16.1 – $33.34
- One year
- −13.59%
Overview
- Symbol
- STAA
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
STAAR Surgical earnings calls (STAA)
Financials
What the filings say
Net profit, year on year: +148% (quarter to jul 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 89 | 49 | 43 | 44 | 95 | 58 | 94 | 94 |
| Operating profit | 6 | -28 | -57 | -30 | 18 | -23 | 8 | 10 |
| Operating margin | 6.4% | −57.0% | −134.8% | −67.6% | 19.5% | −39.5% | 8.5% | 10.8% |
| Other income | 7 | -2 | 3 | 4 | 0 | 2 | 0 | 1 |
| Profit before tax | 13 | -30 | -54 | -26 | 19 | -21 | 8 | 11 |
| Tax rate | 24.2% | −12.8% | 0.5% | 35.1% | 52.7% | 11.3% | 36.6% | 26.9% |
| Net profit | 10 | -34 | -54 | -17 | 9 | -18 | 5 | 8 |
| EPS ($ per share) | 0.20 | — | -1.10 | -0.34 | 0.18 | — | 0.10 | 0.16 |
| Line item | Dec 2018 | Jan 2020 | Jan 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -156 | -142 | -136 | -108 | -69 | -47 | -68 | -148 |
| Total liabilities | 35 | 48 | 60 | 87 | 83 | 103 | 112 | 107 |
| Fixed assets | 11 | 17 | 24 | 36 | 51 | 67 | 85 | 73 |
| Investments | — | — | — | — | 125 | 38 | 86 | 34 |
| Total assets | 167 | 208 | 257 | 346 | 419 | 489 | 510 | 452 |
| Line item | Dec 2018 | Jan 2020 | Jan 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 13 | 26 | 21 | 44 | 36 | 15 | 16 | -34 |
| Cash from investing | -2 | -10 | -8 | -14 | -156 | 74 | -59 | 46 |
| Cash from financing | 75 | 0 | 20 | 18 | 8 | 7 | 6 | -5 |
| Net cash flow | 85 | 16 | 32 | 47 | -113 | 97 | -39 | 9 |
| Capital expenditure | -2 | -10 | -8 | -14 | -18 | -18 | -23 | -6 |
| Free cash flow | 11 | 16 | 13 | 30 | 18 | -4 | -8 | -40 |
Insider filings
75 filings between Nov 12, 2025 and Aug 14, 2026.
Open market
decisions to buy or sellPurchases
$62.75M
22 purchases by 1 insider
Sales
None
No insider sold shares.
Compensation
not trading decisions- 11
- Award — granted as compensation
- 19
- Option exercise — converted options into shares
- 23
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | $62.75M | — | Mar 13, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | Michna Magda Chief Development Officer | Option exercise | 1,100 | $28.8K |
| Aug 14, 2026 | Michna Magda Chief Development Officer | Option exercise | 5,499 | $0 |
| Aug 14, 2026 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Tax withheld | 2,662 | $69.7K |
| Aug 14, 2026 | Michna Magda Chief Development Officer | Tax withheld | 559 | $14.6K |
| Aug 14, 2026 | Foust Warren President and CEO | Tax withheld | 1,865 | $48.8K |
| Aug 14, 2026 | Foust Warren President and CEO | Option exercise | 7,331 | $0 |
| Aug 14, 2026 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Option exercise | 5,233 | $0 |
| Aug 14, 2026 | Foust Warren President and CEO | Option exercise | 3,666 | $0 |
| Aug 14, 2026 | Foust Warren President and CEO | Tax withheld | 3,730 | $97.7K |
| Aug 14, 2026 | Michna Magda Chief Development Officer | Tax withheld | 2,797 | $73.2K |
| Jul 31, 2026 | Foust Warren President and CEO | Option exercise | 20,787 | — |
| Jul 31, 2026 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Option exercise | 20,787 | — |
| Jul 31, 2026 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Tax withheld | 10,576 | $257.6K |
| Jul 31, 2026 | Foust Warren President and CEO | Tax withheld | 10,576 | $257.6K |
| Jun 25, 2026 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Tax withheld | 6,480 | $202.2K |
| Jun 25, 2026 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Option exercise | 13,955 | — |
| Jun 18, 2026 | SILVERMAN LOU Director | Option exercise | 10,683 | $0 |
| Jun 18, 2026 | Butcher Arthur C Director | Option exercise | 5,341 | $0 |
| Jun 18, 2026 | Jiang Wei Director | Option exercise | 10,683 | $0 |
| Jun 12, 2026 | Zhou Lilian Yansheng Director | Award | 3,530 | $99.9K |
| May 15, 2026 | Michna Magda Chief Development Officer | Tax withheld | 1,118 | $35.9K |
| May 15, 2026 | Michna Magda Chief Development Officer | Award | 2,199 | $0 |
| May 15, 2026 | Michna Magda Chief Development Officer | Tax withheld | 2,431 | $78.0K |
| May 15, 2026 | Michna Magda Chief Development Officer | Award | 5,499 | $0 |
| May 15, 2026 | Michna Magda Chief Development Officer | Tax withheld | 5,595 | $179.4K |
| May 15, 2026 | ANDREWS DEBORAH J Interim Co-CEO and CFO | Tax withheld | 1,877 | $60.2K |
| May 15, 2026 | Michna Magda Chief Development Officer | Award | 10,997 | $0 |
| May 15, 2026 | ANDREWS DEBORAH J Interim Co-CEO and CFO | Tax withheld | 3,755 | $120.4K |
| May 15, 2026 | Foust Warren Interim Co-CEO and Pres. & COO | Tax withheld | 1,865 | $59.8K |
| May 15, 2026 | Michna Magda Chief Development Officer | Award | 1,100 | $0 |
| May 15, 2026 | ANDREWS DEBORAH J Interim Co-CEO and CFO | Award | 10,466 | $0 |
| May 15, 2026 | ANDREWS DEBORAH J Interim Co-CEO and CFO | Award | 5,233 | $0 |
| May 15, 2026 | Foust Warren Interim Co-CEO and Pres. & COO | Tax withheld | 3,730 | $119.6K |
| May 15, 2026 | Foust Warren Interim Co-CEO and Pres. & COO | Award | 7,331 | $0 |
| May 15, 2026 | Foust Warren Interim Co-CEO and Pres. & COO | Tax withheld | 3,730 | $119.6K |
| May 15, 2026 | Foust Warren Interim Co-CEO and Pres. & COO | Award | 7,331 | $0 |
| May 15, 2026 | Foust Warren Interim Co-CEO and Pres. & COO | Tax withheld | 7,460 | $239.2K |
| May 15, 2026 | Foust Warren Interim Co-CEO and Pres. & COO | Award | 3,666 | $0 |
| May 15, 2026 | Foust Warren Interim Co-CEO and Pres. & COO | Award | 14,662 | $0 |
| May 15, 2026 | Michna Magda Chief Development Officer | Tax withheld | 559 | $17.9K |
| May 8, 2026 | Michna Magda Chief Development Officer | Tax withheld | 1,680 | $44.8K |
| May 8, 2026 | Foust Warren Interim Co-CEO and Pres. & COO | Tax withheld | 3,448 | $92.0K |
| Mar 14, 2026 | Foust Warren Interim Co-CEO and Pres. & COO | Option exercise | 9,775 | $0 |
| Mar 14, 2026 | Foust Warren Interim Co-CEO and Pres. & COO | Option exercise | 19,550 | $0 |
| Mar 14, 2026 | Michna Magda Chief Development Officer | Tax withheld | 6,313 | $118.9K |
| Mar 14, 2026 | Michna Magda Chief Development Officer | Option exercise | 2,932 | $0 |
| Mar 14, 2026 | Michna Magda Chief Development Officer | Option exercise | 14,663 | $0 |
| Mar 13, 2026 | BROADWOOD PARTNERS, L.P. Director | Purchase | 0 | $0 |
| Mar 13, 2026 | BROADWOOD PARTNERS, L.P. Director | Purchase | 316,017 | $5.88M |
| Mar 12, 2026 | Foust Warren Interim Co-CEO and Pres. & COO | Option exercise | 8,175 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for STAAR SURGICAL CO
Free account. Everything above stays public.
Write why you follow STAAR SURGICAL CO and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading